Optimized Production of Lentiviral Vectors for CAR-T Cell
Author:
Publisher
Springer US
Link
http://link.springer.com/content/pdf/10.1007/978-1-0716-0146-4_5
Reference17 articles.
1. Brentjens RJ, Davila ML, Riviere I et al (2013) CD19-targeted t cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med 5:177ra38. https://doi.org/10.1126/scitranslmed.3005930
2. Kochenderfer JN, Dudley ME, Carpenter RO et al (2013) Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood 122:151. https://doi.org/10.1182/blood-2013-08-519413.R.E.G
3. Kochenderfer JN, Dudley ME, Kassim SH et al (2015) Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J Clin Oncol 33:540–549. https://doi.org/10.1200/JCO.2014.56.2025
4. Kalos M, Levine BL, Porter DL et al (2011) T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med 3:95ra73. https://doi.org/10.1126/scitranslmed.3002842
5. Beatty GL, Haas AR, Maus MV et al (2014) Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce antitumor activity in solid malignancies. Cancer Immunol Res 2:112–120. https://doi.org/10.1158/2326-6066.CIR-13-0170
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Engagement of an optimized lentiviral vector enhances the expression and cytotoxicity of CAR in human NK cells;Molecular Immunology;2023-03
2. Anti-ROR1 CAR-T cells: Architecture and performance;Frontiers in Medicine;2023-02-17
3. Impact of Manufacturing Procedures on CAR T Cell Functionality;Frontiers in Immunology;2022-04-13
4. Aberrant splicing events caused by insertion of genes of interest into expression vectors;International Journal of Biological Sciences;2022
5. Adoptive T-cell Immunotherapy: Perfecting Self-Defenses;Experientia Supplementum;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3